Cathay Fortune International failed to acquire Epigenomics.

Synopsis

Cathay Fortune International, an investment company, failed to acquire Epigenomics, a Germany-based molecular diagnostics company. Financial terms were not disclosed.

Principals

target

Epigenomics

bidder

Cathay Fortune Corporation

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (4)

yilong du

Latham & Watkins

Lawyer

bidder

Deals

£ 10 M

Total Value

dirk kocher

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 10.14 B

Total Value

harald selzner

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 4.41 B

Total Value

qiuning (frank) sun

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 8.59 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy